New Study Finds FDA Drug Recalls Not Well Publicized
FDA recalls potentially dangerous drugs about once per month, but the agency could better inform physicians and patients about its decisions, according to a study published in the Archives of Internal Medicine. Between 2004 and 2011, FDA failed to utilize two of its electronic alert systems to publicize one-fifth of Class 1 drug recalls, which FDA has designated for medications that could potentially cause "serious adverse health consequences or death."
- "U.S. Drug Recalls Common, Not Well Publicized: Study" (Seaman, Reuters, 6/4).